| Novel |
APOBEC3F
|
apolipoprotein B mRNA editing enzyme catalytic subunit 3F |
|
|
|
| Novel |
ARMC6
|
armadillo repeat containing 6 |
|
|
|
| Novel |
DHX9
|
DExH-box helicase 9 |
- RIP-mediated NFkB activation via ZBP1
- DEx/H-box helicases activate type I IFN and inflammatory cytokines production
- mRNA Splicing - Major Pathway
- PKR-mediated signaling
|
|
|
| Novel |
MTTP
|
microsomal triglyceride transfer protein |
- VLDL assembly
- Chylomicron assembly
- LDL remodeling
|
- Hesperetin
- Implitapide
- SLx-4090
- Lomitapide
|
- Abetalipoproteinemia; Bassen-Kornzweig Disease
|
| Novel |
PRDX2
|
peroxiredoxin 2 |
- Detoxification of Reactive Oxygen Species
- TP53 Regulates Metabolic Genes
- Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
|
- 3-sulfino-L-alanine
- N-Carbamoyl-Alanine
- Copper
|
|
| Novel |
RAB11B
|
RAB11B, member RAS oncogene family |
- TBC/RABGAPs
- RAB geranylgeranylation
|
|
|
| Novel |
SULT1A1
|
sulfotransferase family 1A member 1 |
- Cytosolic sulfonation of small molecules
- Paracetamol ADME
|
- Adenosine 3',5'-diphosphate
- P-Nitrophenol
|
|
| Novel |
ZNF177
|
zinc finger protein 177 |
|
|
|
|
CBL
|
Cbl proto-oncogene |
- Interleukin-6 signaling
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
- Spry regulation of FGF signaling
- Regulation of KIT signaling
- EGFR downregulation
- TGF-beta receptor signaling activates SMADs
- Constitutive Signaling by EGFRvIII
- Negative regulation of FGFR1 signaling
- Negative regulation of FGFR2 signaling
- Negative regulation of FGFR3 signaling
- Negative regulation of FGFR4 signaling
- Negative regulation of MET activity
- PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- InlB-mediated entry of Listeria monocytogenes into host cell
- InlB-mediated entry of Listeria monocytogenes into host cell
- Regulation of signaling by CBL
- Regulation of signaling by CBL
- Signaling by CSF1 (M-CSF) in myeloid cells
- Negative regulation of FLT3
- FLT3 signaling by CBL mutants
|
|
- Noonan syndrome and related disorders, including: Noonan syndrome (NS); Leopard syndrome (LS); Noonan syndrome-like with loose anagen hair (NS/LAH); CBL-mutation associated syndrome (CBL); Neurofibromatosis type 1 (NF1); Neurofibromatosis type 2 (NF2); Neurofibromatosis-Noonan syndrome (NFNS); Legius syndrome; Cardiofaciocutaneous syndrome (CFCS); Costello syndrome (CS)
|
|
COPS5
|
COP9 signalosome subunit 5 |
- DNA Damage Recognition in GG-NER
- Formation of TC-NER Pre-Incision Complex
- Cargo recognition for clathrin-mediated endocytosis
- Neddylation
- GSK3B-mediated proteasomal degradation of PD-L1(CD274)
|
|
|
|
CRKL
|
CRK like proto-oncogene, adaptor protein |
- Frs2-mediated activation
- Frs2-mediated activation
- Downstream signal transduction
- MET activates RAP1 and RAC1
- MET receptor recycling
- Erythropoietin activates RAS
- Erythropoietin activates RAS
- Regulation of signaling by CBL
|
|
|
|
CYSRT1
|
cysteine rich tail 1 |
|
|
|
|
DNM2
|
dynamin 2 |
- Toll Like Receptor 4 (TLR4) Cascade
- Retrograde neurotrophin signalling
- Gap junction degradation
- Formation of annular gap junctions
- NOSTRIN mediated eNOS trafficking
- MHC class II antigen presentation
- Lysosome Vesicle Biogenesis
- Golgi Associated Vesicle Biogenesis
- Recycling pathway of L1
- Clathrin-mediated endocytosis
- NGF-stimulated transcription
- Degradation of CDH1
|
|
- Centronuclear myopathy
- Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2 alpha kinase 2 |
- ISG15 antiviral mechanism
- Inhibition of PKR
- SUMOylation of immune response proteins
- Interferon alpha/beta signaling
- Evasion by RSV of host interferon responses
- PKR-mediated signaling
|
- Indomethacin
- H-89
- Fostamatinib
|
|
|
FHL3
|
four and a half LIM domains 3 |
|
|
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase |
- GPVI-mediated activation cascade
- Signaling by ERBB2
- PIP3 activates AKT signaling
- Signaling by SCF-KIT
- Signaling by SCF-KIT
- Regulation of KIT signaling
- Nef and signal transduction
- Cell surface interactions at the vascular wall
- FCGR activation
- PECAM1 interactions
- Constitutive Signaling by Aberrant PI3K in Cancer
- DAP12 signaling
- DAP12 signaling
- EPH-Ephrin signaling
- Role of LAT2/NTAL/LAB on calcium mobilization
- Nephrin family interactions
- Nephrin family interactions
- NCAM signaling for neurite out-growth
- NCAM signaling for neurite out-growth
- Co-stimulation by CD28
- CD28 dependent PI3K/Akt signaling
- CD28 dependent Vav1 pathway
- Co-inhibition by CTLA4
- EPHB-mediated forward signaling
- EPHB-mediated forward signaling
- EPHA-mediated growth cone collapse
- EPHA-mediated growth cone collapse
- Ephrin signaling
- Ephrin signaling
- EPH-ephrin mediated repulsion of cells
- Sema3A PAK dependent Axon repulsion
- SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
- SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
- CRMPs in Sema3A signaling
- CRMPs in Sema3A signaling
- VEGFA-VEGFR2 Pathway
- Dectin-2 family
- CD209 (DC-SIGN) signaling
- RAF/MAP kinase cascade
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- Platelet Adhesion to exposed collagen
- Reelin signalling pathway
- Regulation of signaling by CBL
- Regulation of signaling by CBL
- FCGR3A-mediated IL10 synthesis
- FCGR3A-mediated phagocytosis
- Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
- Signaling by CSF1 (M-CSF) in myeloid cells
- FLT3 signaling through SRC family kinases
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
|
- Dasatinib
- Triglyme
- Fostamatinib
- Zotiraciclib
|
|
|
GHR
|
growth hormone receptor |
- Prolactin receptor signaling
- Growth hormone receptor signaling
- Growth hormone receptor signaling
|
- Somatotropin
- Pegvisomant
- Somatrem
- Somapacitan
- Lonapegsomatropin
|
- Pituitary Dwarfism (PD); Isolated growth hormone deficiency (IGHD); Short Stature and Pituitary Defects (SSPD); Insulin-like growth factor 1 deficiency (IGFD)
|
|
GOLGA6L9
|
golgin A6 family like 9 |
|
|
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K |
- SUMOylation of RNA binding proteins
- mRNA Splicing - Major Pathway
- Processing of Capped Intron-Containing Pre-mRNA
- HCMV Late Events
|
- Artenimol
- Phenethyl Isothiocyanate
|
|
|
IFNAR1
|
interferon alpha and beta receptor subunit 1 |
- Interferon alpha/beta signaling
- Regulation of IFNA/IFNB signaling
- Regulation of IFNA/IFNB signaling
- Potential therapeutics for SARS
- SARS-CoV-2 activates/modulates innate and adaptive immune responses
- Evasion by RSV of host interferon responses
|
- Peginterferon alfa-2a
- Interferon alfa-n1
- Interferon alfa-n3
- Peginterferon alfa-2b
- Interferon alfa-2a
- Interferon beta-1a
- Interferon beta-1b
- Interferon alfacon-1
- Interferon alfa-2b
- Interferon alfa
- Human interferon omega-1
- Peginterferon beta-1a
- Anifrolumab
- Human interferon beta
- Ropeginterferon alfa-2b
|
|